IRIS
MAGLIANI, Valter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.349
AS - Asia 9.360
EU - Europa 8.076
SA - Sud America 2.011
AF - Africa 564
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 4
Totale 30.386
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.982
SG - Singapore 3.686
CN - Cina 3.342
BR - Brasile 1.587
UA - Ucraina 1.492
IE - Irlanda 1.304
DE - Germania 1.298
FI - Finlandia 1.063
IT - Italia 896
VN - Vietnam 893
SE - Svezia 891
HK - Hong Kong 773
ZA - Sudafrica 418
NL - Olanda 393
CA - Canada 268
TR - Turchia 189
AR - Argentina 163
GB - Regno Unito 155
RU - Federazione Russa 151
AT - Austria 142
EC - Ecuador 101
IN - India 80
FR - Francia 74
MX - Messico 65
BD - Bangladesh 62
IQ - Iraq 57
JP - Giappone 54
ID - Indonesia 47
BE - Belgio 44
CO - Colombia 41
PL - Polonia 39
MA - Marocco 37
PY - Paraguay 34
ES - Italia 30
VE - Venezuela 30
KE - Kenya 27
PK - Pakistan 26
CL - Cile 25
EG - Egitto 22
EU - Europa 19
RO - Romania 19
JO - Giordania 17
TN - Tunisia 17
KZ - Kazakistan 15
IL - Israele 14
UY - Uruguay 14
CZ - Repubblica Ceca 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
LT - Lituania 12
CI - Costa d'Avorio 10
NP - Nepal 10
KR - Corea 9
BG - Bulgaria 8
PE - Perù 8
SA - Arabia Saudita 8
OM - Oman 7
BO - Bolivia 6
ET - Etiopia 6
HN - Honduras 6
TT - Trinidad e Tobago 6
AL - Albania 5
CR - Costa Rica 5
DZ - Algeria 5
IR - Iran 5
BB - Barbados 4
BY - Bielorussia 4
CH - Svizzera 4
EE - Estonia 4
HU - Ungheria 4
LB - Libano 4
NG - Nigeria 4
NI - Nicaragua 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GE - Georgia 3
JM - Giamaica 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZW - Zimbabwe 3
BW - Botswana 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KW - Kuwait 2
LK - Sri Lanka 2
NO - Norvegia 2
TG - Togo 2
TH - Thailandia 2
AM - Armenia 1
AU - Australia 1
Totale 30.363
Salva come PNG Salva come JPEG
Città #
Singapore 1.747
Jacksonville 1.542
Dublin 1.301
Chandler 1.006
Beijing 955
Ashburn 893
Hong Kong 767
Dearborn 762
Santa Clara 508
Boardman 498
Nanjing 485
Dallas 397
Johannesburg 392
Princeton 365
Ho Chi Minh City 343
Ann Arbor 286
San Mateo 285
Munich 261
Toronto 207
Wilmington 207
Parma 177
Hanoi 171
Kunming 171
Bremen 167
Helsinki 166
New York 157
Shenyang 155
Hefei 154
Izmir 151
Nanchang 139
Vienna 130
São Paulo 125
Los Angeles 121
Hebei 118
Moscow 116
Shanghai 116
Des Moines 100
Jinan 94
Tianjin 71
Grafing 68
Jiaxing 63
Changsha 57
Guangzhou 55
Rio de Janeiro 55
Buffalo 52
Woodbridge 51
Seattle 48
Norwalk 47
Turku 47
Brussels 42
Columbus 40
Rome 39
Brasília 38
Düsseldorf 37
Haiphong 37
Fremont 34
Warsaw 34
Zhengzhou 33
Da Nang 32
Marseille 32
Tokyo 32
Hangzhou 31
Quito 31
Guayaquil 29
Brooklyn 28
Houston 28
Bắc Ninh 26
Chengdu 24
Biên Hòa 23
Milan 23
Nairobi 23
Porto Alegre 23
Salvador 23
The Dalles 22
Belo Horizonte 21
Curitiba 21
Atlanta 20
Baghdad 20
Fuzhou 20
Campinas 19
Council Bluffs 18
Denver 18
Fortaleza 18
San Francisco 18
Amman 17
Can Tho 17
Chennai 17
Frankfurt am Main 17
Jakarta 17
London 17
Ningbo 17
Ribeirão Preto 17
Thái Bình 17
Boston 16
Buenos Aires 16
Chicago 16
Hải Dương 16
Montreal 16
Phoenix 16
Orem 15
Totale 17.570
Salva come PNG Salva come JPEG
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 254
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 228
Capitolo 5. Differenziamento reale e differenziamento temporaneo. 223
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 179
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 177
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 176
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 175
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 170
Antibodies as a source of anti-infective peptides: an update 163
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 158
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 156
Cap. 6. Differenziamento reale e differenziamento temporaneo. 151
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 150
Antifungal peptides within the antibodies 150
A synthetic peptide as a novel anticryptococcal agent 149
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 147
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 147
L'identificazione dei batteri Gram negativi mediante il sistema ATB. 146
Screening of thiosemicarbazones as antimycotic drugs 146
Metabolic profiling of Candida albicans 145
Fungicidal activity of peptides encoded by immunoglobulin genes 144
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 143
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 141
Antifungal activity of the C-terminal peptide from human serum albumin 136
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 136
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 136
Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP) 135
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 134
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3+CD16+ natural killer T cells and CD4+CD8α+ double positive CD8β+ cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion 133
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 132
Peptides from the inside of the antibodies are active against infectious agents and tumours 132
Antibody peptide based antifungal immunotherapy 131
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 131
Anti-septic shock recombinant vaccine. 130
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 129
Antibody-mediated protective immunity in fungal infections 129
Natural and synthetic peptides with antifungal activity 128
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 127
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 126
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 123
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 122
Agenti virali di gastroenterite. 122
Anticorpi immagini interne di tossine killer 122
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 120
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 119
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 118
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 118
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 117
Antireceptor yeast killer toxin-like antibiobodies 115
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 115
Wickerhamomyces yeast killer toxins’ medical applications 115
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 114
Anticorpi antibiotici ricombinanti ad attività terapeutica fungicida. 113
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 113
Antibiobodies: antibiotic-like antiidiotypic antibodies. 113
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 112
Antibiobodies: antibiotic internal image antibodies 111
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 111
Il sistema immunoenzimatico GM1 ELISA per la ricerca della tossina termolabile di E. coli. 110
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 110
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 109
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 109
Mode of action of a killer peptide against Toxoplasma gondii 109
Innate antimicrobial and antiviral activities of antibody peptides 108
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 108
In vitro and in vivo anticandidal activity of killer peptide derivatives 107
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 106
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 105
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 105
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 105
Metabolic profile of Candida albicans 104
L'elettroferotipo come mezzo di indagine epidemiologica nelle gastroenteriti da rotavirus umani. 103
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 101
Valutazione di alcuni aspetti della nuova tecnologia VITEK2 effettuata presso gli Istituti di Microbiologia dell'Università di Parma e dell'Università Cattolica di Roma. Workshop: VITEK2: un mondo d'innovazione. 101
Antibodies as Crypts of Antiinfective and Antitumor Peptides 100
Valutazione di un nuovo sistema automatizzato per l'identificazione e l'antibiogramma: L'identificazione rapida. Workshop: Recenti sviluppi e nuove prospettive dei metodi automatizzati per l'identificazione e l'antibiogramma. 99
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 99
Antibiotic antibodies 99
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 98
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 97
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 97
Restriction of Influenza virus multiplication induced by PK peptide treatment 97
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 97
Applicazioni della Biologia Molecolare in Micologia. 96
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 96
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 95
Antibiotic assay-based treatment of Helicobacter Pylori ( HP ) infection. 95
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 94
Any antibody fragment might exert antifungal activity 93
Protective antifungal yeast killer toxin-like antibodies 92
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 92
Immunizzazione neonatale nei confronti dell'infezione da streptococco di gruppo B mediante vaccini antiidiotipici ricombinanti. 91
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity 91
L'automazione integrata nel Laboratorio di Batteriologia. 91
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 91
Spettro d'azione universale di mimotopi killer antifungini 90
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 90
Automazione dell’antibiogramma diretto sulle urine. 90
Indagini batteriologiche e virologiche su campioni di feci in pazienti affetti da gastroenterite acuta osservati presso gli Ospedali Riuniti di Parma. 89
Human natural yeast killer toxin-like antibodies 89
Totale 12.284
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.303 0 0 0 0 0 27 325 21 480 46 352 52
2021/20221.638 27 4 17 62 52 86 226 300 66 109 157 532
2022/20234.451 594 381 220 287 474 513 28 230 1.571 18 91 44
2023/20241.528 92 163 83 40 136 427 41 72 25 79 126 244
2024/20255.546 48 415 404 285 412 536 157 193 946 602 380 1.168
2025/20267.428 1.015 1.300 1.546 1.603 1.696 268 0 0 0 0 0 0
Totale 30.549